No Benefit of Saxagliptin on Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Potential Explanations

被引：1
|
作者：
Jialal, Ishwarlal [1 ]
Dhindsa, Sandeep [2 ]
机构：
[1] Univ Calif Davis, Med Ctr, Lab Atherosclerosis & Metab Res, Sacramento, CA 95817 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Div Endocrinol & Metab, Odessa, TX USA
来源：
METABOLIC SYNDROME AND RELATED DISORDERS | 2014年 / 12卷 / 03期
关键词：
DIPEPTIDYL PEPTIDASE-4 INHIBITORS; THERAPY;
D O I：
10.1089/met.2014.1500
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [31] Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
    Bangalore, Sripal
    Fayyad, Rana
    DeMicco, David A.
    Colhoun, Helen M.
    Waters, David D.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (11): : e004724
  • [32] Type 2 diabetes mellitus and cardiovascular disease: focus on the effect of antihyperglycemic treatments on cardiovascular outcomes
    Choxi, Ravi
    Roy, Sumon
    Stamatouli, Angeliki
    Mayer, Stephanie B.
    Jovin, Ion S.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (04) : 187 - 199
  • [33] Saxagliptin Monotherapy or Combination Therapy: Outcomes by Duration of Type 2 Diabetes
    Iqbal, Nayyar
    Allen, Elsie
    Donovan, Mark
    Ohman, Peter
    DIABETES, 2012, 61 : A619 - A620
  • [34] Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors
    Hayden, JM
    Reaven, PD
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (05) : 519 - 528
  • [35] Type 2 diabetes mellitus: a cardiovascular perspective
    Varughese, GI
    Tomson, J
    Lip, GYH
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (07) : 798 - 816
  • [36] Cardiovascular risk in type 2 diabetes mellitus
    Hohberg, C.
    Roth, W.
    Luebben, G.
    Forst, T.
    Gauert, S.
    Karagiannis, F.
    Reimer, T.
    Gottschall, V.
    Pfuetzner, A.
    DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (03): : 173 - 177
  • [37] Efficacy and Tolerability of Saxagliptin (SAXA) in Patients With Type 2 Diabetes Mellitus (T2DM) and a History of Cardiovascular Disease (CVD)
    Minervini, Gianmaria
    Cook, William
    Allen, Elsie
    DIABETES, 2013, 62 : A306 - A306
  • [38] Saxagliptin: A Review in Type 2 Diabetes
    Dhillon, Sohita
    DRUGS, 2015, 75 (15) : 1783 - 1796
  • [39] Saxagliptin: A Review in Type 2 Diabetes
    Sohita Dhillon
    Drugs, 2015, 75 : 1783 - 1796
  • [40] Saxagliptin (Onglyza) for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1324): : 85 - 86
12345